Cleveland Clinic opened the Medical Intensive Liver Unit in the summer of 2018, one of few in the U.S. Critical care physicians, Hassan Khouli, MD and Aanchal Kapoor, MD discuss the program and share promising outcomes data on transplant-free survival for patients with cirrhosis.
World-renowned transplant surgeon David Kwon, MD, recently joined Cleveland Clinic’s Digestive Disease & Surgery Institute as Director of Laparoscopic Liver Surgery. He and Koji Hashimoto, MD, PhD, Director of Living Donor Liver Transplantation, discuss what Dr. Kwon’s arrival means for Cleveland Clinic’s LDLT program.
A 65-year-old female with PBC and a 54-year-old male with hepatitis C-related cirrhosis and HCC benefit from simultaneous liver transplants from one deceased donor.
Cleveland Clinic surgeons used a new transplant protocol to treat a patient with liver metastases from colorectal cancer for the first time in the U.S. Learn how this protocol could improve patient outcomes.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
This case of living donor liver transplantation using a small left lobe graft allowed us to treat a patient with severe portal hypertension, avoiding a crisis due to the shortage of available donor organs.
Meet Sammy: An energetic 8-year-old who received the first multivisceral transplant in a pediatric patient with Alagille syndrome, a rare genetic disorder that can lead to liver failure.
Paradigm shift in transplant medicine: Livers successfully transplanted in Cleveland Clinic study using homegrown normothermic ex vivo perfusion machine rather than cold preservation for maintaining organs.
Cleveland Clinic’s Liver Tumor Clinic provides leading-edge, individualized treatment of complex liver cancer in an innovative multidisciplinary model clinic.
No one needs to tell Dr. Naim Alkhouri that invasive tests for nonalcoholic fatty liver disease are ill-suited to kids. His quest to find a noninvasive alternative has him exploring a host of promising options.
Cleveland Clinic researchers have discovered the reason why some liver transplant patients can stop their immunosuppressive medication safely. New article reveals details about immune control mechanisms.